Georgiamune

Georgiamune

Regulating signaling pathways to restore immune balance and fight cancer and autoimmune diseases, utilizing first-in-class assets with a robust pipeline of immunomodulators.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD464—695m (Dealroom.co estimates Aug 2023.)
Gaithersburg Maryland (HQ)
Authorizing premium user...